Related Experiment Video
Updated: Feb 13, 2026

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
At-Home Pupil Dilation During the COVID-19 Pandemic in the Pediatric Population
Yoav Glidai1,2, Rina Su1,2,3, Jake L Diamond2
1Northwell, New Hyde Park, New York.
Insights
Caregivers found at-home pupil dilation (AHPD) feasible and cost-effective during the COVID-19 pandemic. Most would consider AHPD again, citing convenience and time savings, despite some challenges with difficulty and cost.
Area of Science:
- Ophthalmology
- Pediatric Care
- Public Health
Background:
- The COVID-19 pandemic necessitated adaptations in healthcare delivery, including pediatric ophthalmology.
- At-home pupil dilation (AHPD) emerged as a potential solution to maintain eye care access.
- Caregiver perspectives on AHPD were largely unevaluated prior to this study.
Purpose of the Study:
- To assess caregiver experiences with at-home pupil dilation (AHPD) for children.
- To identify challenges and difficulties encountered by caregivers during AHPD.
- To evaluate the feasibility and acceptance of AHPD during the COVID-19 pandemic.
Main Methods:
- Retrospective questionnaire study involving caregivers of children younger than 6 years.
- Eligibility for AHPD determined by a pediatric ophthalmologist.
- Cyclopentolate 1% eye drops were prescribed; age groups were analyzed.
Main Results:
- 73.9% of respondents successfully completed AHPD.
- Mean task difficulty was 3.36 ± 1.44; no significant differences between age groups.
- 65.8% would consider AHPD in the future; 63% found it time-saving and worthwhile.
- Primary barriers included difficulty (34.8%), cost (30.4%), and unclear instructions (8.7%).
Conclusions:
- At-home pupil dilation (AHPD) is a potentially useful, cost-effective, and convenient option for pediatric eye exams.
- AHPD may reduce patient anxiety associated with in-office procedures.
- Individualized decisions regarding AHPD should consider child-specific needs, parental capacity, and the ophthalmologic condition.
Purpose:
To evaluate caregivers' perspectives, challenges, and difficulties associated with at-home pupil dilation (AHPD) during the coronavirus disease 2019 (COVID-19) pandemic.
Methods:
In this retrospective questionnaire study, a pediatric ophthalmologist determined eligibility for AHPD in children younger than 6 years. Cyclopentolate 1% eye drops were prescribed. Age was recorded and divided into three age groups.
Results:
Of 264 respondents, 73.9% (n = 195) completed AHPD, with half having undergone eye dilation in the past (53.7%, n = 116). The mean task difficulty across all groups was 3.36 ± 1.44 (range: 1 to 5). There were no statistical differences in difficulty between groups. Most caregivers stated that they would consider AHPD in the future (65.8%), and 63% reported that this practice saved time and was worth the cost and difficulty associated with AHPD. For more than 80% of responders, the cost was less than 20 United States Dollars, and 41.8% did not need to pay for their drops. The common reasons for not performing AHPD were difficulty (34.8%, n = 24), cost of the drops (30.4%, n = 21), and unclear instructions (8.7%, n = 6).
Conclusions:
AHPD can be a useful and cost-effective tool, can offer convenience, and may reduce anxiety in the office. The decision to use this approach should be individualized, considering the child's specific needs, parental comfort and ability, and the nature of the assessed ophthalmologic condition.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Conservation of Small Populations
What is Population Genetics?
Population Growth
What are Populations and Communities?
Other Nuclides: 31P, 19F, 15N NMR
While fluorine-19 and phosphorous-31 have high natural abundances (100%) and positive gyromagnetic ratios, nitrogen-15 has a low natural abundance and a negative gyromagnetic ratio. However, nitrogen-15 is still preferred over nitrogen-14 (which has a...

